Livealth Biopharma Private Limited
Indian Pharmaceutical Exporter ยท Antiviral & HIV Medications Specialist ยท $331.4K Total Trade ยท DGFT Verified
Livealth Biopharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $331.4K across 4 products in 3 therapeutic categories. Based on 26 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ritonavir ($200.0K), Atovaquone ($45.6K), Proguanil ($45.6K).
Livealth Biopharma Private Limited โ Export Portfolio & Destination Treemap

Who is Livealth Biopharma Private Limited? โ Company Overview & Market Position
Livealth Biopharma Private Limited, established on March 15, 2016, is a privately held pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24296MH2016PTC274406. Its authorized capital stands at โน1.00 crore, with a paid-up capital of โน0.10 million. The registered office is located at 606 Dev Plaza, Opp. Andheri Fire Brigade, S. V. Road, Mumbai, Maharashtra, 400058.
Livealth Biopharma specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's product portfolio spans various therapeutic categories, with a notable focus on antiviral and HIV medications, antimalarial and antiparasitic drugs, and advanced antibiotics. As of the financial year ending March 31, 2025, the company reported a significant growth trajectory, with a 52.05% increase in total revenue and a 107.55% rise in profit. The net worth also saw an impressive increase of 87.04%.